FR940705-2-00162 FR940705-2-00091 Tuesday July 5, 1994 Part IV Department of Health and Human Services National Institutes of Health Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines); Notice Federal Register ␣/␣Vol. 59, No. 127␣/␣Tuesday, July 5, 1994␣/␣Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines) June 1994. These NIH Guidelines supersede all earlier versions and shall be in effect until further notice. Table of Contents Section I. Scope of the NIH Guidelines Section I&hyph;A. Purpose Section I&hyph;B. Definition of Recombinant DNA Molecules Section I&hyph;C. General Applicability Section I&hyph;D. General Definitions Section II. Containment Section III. Experiments Covered by the NIH Guidelines Section III&hyph;A. Experiments that Require Institutional Biosafety Committee Approval, RAC Review, and NIH Approval Before Initiation Section III&hyph;B. Experiments that Require NIH/ORDA and Institutional Biosafety Committee Approval Before Initiation Section III&hyph;B&hyph;1. Experiments Involving the Cloning of Toxin Molecules with LD 50 of Less than 100 Nanograms Per Kilogram Body Weight Section III&hyph;B&hyph;2. Accelerated Review of Human Gene Transfer Experiments Section III&hyph;B&hyph;3. Minor Modifications to Human Gene Transfer Experiments Section III&hyph;C. Experiments that Require Institutional Biosafety Committee Approval Before Initiation Section III&hyph;C&hyph;1. Experiments Using Human or Animal Pathogens (Class 2, Class 3, Class 4, or Class 5) Agents as Host-Vector Systems Section III&hyph;C&hyph;2. Experiments in which DNA from Human or Animal Pathogens (Class 2, Class 3, Class 4, or Class 5) Agents is Cloned into Nonpathogenic Prokaryotic or Lower Eukaryotic Host-Vector Systems Section III&hyph;C&hyph;3. Experiments Involving the Use of Infectious Animal or Plant DNA or RNA Viruses or Defective Animal or Plant DNA or RNA Viruses in the Presence of Helper Virus in Tissue Culture Systems Section III&hyph;C&hyph;4. Experiments Involving Whole Animals Section III&hyph;C&hyph;5. Experiments Involving Whole Plants Section III&hyph;C&hyph;6. Experiments Involving More than 10 Liters of Culture Section III&hyph;C&hyph;7. Human Gene Transfer Experiments Not Covered by Section III&hyph;A&hyph;2, III&hyph;B&hyph;2, III&hyph;B&hyph;3, and Not Considered Exempt under Section V&hyph;U Section III&hyph;D. Experiments that Require Institutional Biosafety Committee Notice Simultaneous with Initiation Section III&hyph;D&hyph;1. Experiments Involving the Formation of Recombinant DNA Molecules Containing No More than Two-Thirds of the Genome of any Eukaryotic Virus Section III&hyph;D&hyph;2. Experiments Involving Whole Plants Section III&hyph;E. Exempt Experiments Section IV. Roles and Responsibilities Section IV&hyph;A. Policy Section IV&hyph;B. Responsibilities of the Institution Section IV&hyph;B&hyph;1. General Information Section IV&hyph;B&hyph;2. Institutional Biosafety Committee (IBC) Section IV&hyph;B&hyph;3. Biological Safety Officer (BSO) Section IV&hyph;B&hyph;4. Principal Investigator (PI) Section IV&hyph;C. Responsibilities of the National Institutes of Health (NIH) Section IV&hyph;C&hyph;1. NIH Director Section IV&hyph;C&hyph;1&hyph;a. General Responsibilities Section IV&hyph;C&hyph;1&hyph;b. Specific Responsibilities Section IV&hyph;C&hyph;1&hyph;b&hyph;(1). Major Actions Section IV&hyph;C&hyph;1&hyph;b&hyph;(2). Minor Actions Section IV&hyph;C&hyph;2. Recombinant DNA Advisory Committee (RAC) Section IV&hyph;C&hyph;3. Office of Recombinant DNA Activities (ORDA) Section IV&hyph;C&hyph;4. Other NIH Components Section IV&hyph;D. Compliance with the NIH Guidelines Section IV&hyph;E. Voluntary Compliance Section V. Footnotes and References of Sections I&hyph;IV
